NASDAQ:ONC BeOne Medicines Q4 2025 Earnings Report $297.65 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$297.77 +0.13 (+0.04%) As of 07/2/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast BeOne Medicines EPS ResultsActual EPS$0.58Consensus EPS $1.60Beat/MissMissed by -$1.02One Year Ago EPSN/ABeOne Medicines Revenue ResultsActual Revenue$1.50 billionExpected Revenue$1.45 billionBeat/MissBeat by +$46.29 millionYoY Revenue GrowthN/ABeOne Medicines Announcement DetailsQuarterQ4 2025Date2/26/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile BeOne Medicines Earnings HeadlinesIs BeOne Medicines AG (ONC) Stock Positioned for Growth After Encouraging ASCO Cancer Data?June 30, 2026 | finance.yahoo.comInsider Selling: BeOne Medicines (NASDAQ:ONC) COO Sells $356,927.92 in StockJune 28, 2026 | americanbankingnews.comTwo Legends Issue Rare Buy Alert on Elon Musk SupplierJeff Brown and Marc Chaikin - the two investors who picked Nvidia before it climbed as much as 36,000% - are issuing a rare joint buy alert on a little-known Elon Musk supplier. They believe Elon Musk's latest AI breakthrough is about to collide with a market pattern that has a 100% track record - one that previously gave everyday investors a chance to turn $10,000 into $350,000 in roughly 12 months.July 4 at 1:00 AM | Brownstone Research (Ad)Financial Analysis: BeOne Medicines (NASDAQ:ONC) versus Aurinia Pharmaceuticals (NASDAQ:AUPH)June 28, 2026 | americanbankingnews.comBeOne Medicines (NASDAQ:ONC) Upgraded at Wall Street ZenJune 28, 2026 | americanbankingnews.comJohn Oyler Sells 3,410 Shares of BeOne Medicines (NASDAQ:ONC) StockJune 27, 2026 | americanbankingnews.comSee More BeOne Medicines Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BeOne Medicines? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BeOne Medicines and other key companies, straight to your email. Email Address About BeOne MedicinesBeOne Medicines (NASDAQ:ONC) Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.View BeOne Medicines ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 06/29 - 07/03Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive WeaponGeneral Mills Is a 5-Star Turnaround Play for Buy and Hold InvestorsCopper Stocks Are Getting a Bigger Spotlight as Gold’s Rally CracksNike Q4 Beat Masks Core Weakness as Analysts Cut Price TargetsIs the Memory Rally Still Alive After the Semiconductor Sell-Off?Hershey Stock May Be Near a Sweet Spot as Cocoa Pressure Eases Upcoming Earnings PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)Fastenal (7/14/2026)Cintas (7/15/2026)ASML (7/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
